Peter Grua - Profile and Investment Details

Investor Profile

Peter Grua is a Venture Capital, Private Equity Firm, Entrepreneurship Program based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as RubiconMD, The IMCS Group, MedVentive, Pathway Medical Technologies, Vets First Choice, Medicalis, ArroHealth, AbleTo, MedSave USA, Aidin, OnShift, Nordic, SensAble Technologies, InnovaCare Health, Summit Microelectronics, meQuilibrium, Regroup Therapy, Array Behavioral Care, TyRx, Interlace Medical, DermTech, Covetrus, mPulse Mobile, RedBrick Health, Valeritas, Aventura Software, Seahorse Bioscience, Satiety, AbilTo, Spinal Kinetics, GTESS Corp, Vantage Oncology, Binary Fountain, Symbion, Teladoc, Carevive Systems, Sanovia Corporation, Vericare Management, Imagine Health, PatientPop, BioProcessors, Linkwell Health, LetsGetChecked, CityLife Health, Radianse, Transcend Medical, Guava Technologies, Phreesia, Casenet, Censinet, Tandem Diabetes Care, Socios Mayores en Salud, Change Healthcare, ClearDATA, Incipient, Aperio Technologies, Oceans Healthcare, CombiMatrix, Welltok. Over time, Peter Grua has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Peter Grua is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Women Founded, Medical Testing, Android, Healthcare Services, Women Led, CRM, Information Technology (IT), Biotech, Analytics, Social Entrepreneurship, Mobile, Software, Healthcare, Supply Chain Management, Veterinary Tech, Digital Marketing, Health Diagnostics, Internet, Medical, SaaS, Therapeutics, mHealth, Media and Entertainment may find it worthwhile to explore potential connections with Peter Grua, as their portfolio suggests a familiarity and interest in this area.

Understanding Peter Grua’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.